Reboxetine is an antidepressant drug used to treat clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Reboxetine methansulphonate and Reboxetine mesilate. Its PubChem CID is 127150.
Reboxetine mesylate
| CAS No | 98769-84-7 |
|---|---|
| Molecular Formula | C20H27NO6S |
| Molecular Weight | 409.5 g/mol |
| Synonyms | (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine;methanesulfonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Reboxetine is an antidepressant drug used to treat clinical depression, panic disorder and ADD/ADHD. e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra.
The listed CAS number is 98769-84-7.
The listed molecular formula is C20H27NO6S.
The listed molecular weight is 409.5 g/mol.
(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine;methanesulfonic acid.
The source lists Reboxetine methansulphonate and Reboxetine mesilate.